1
|
Nesterkina M, Smola S, Rusakova N, Kravchenko I. Terpenoid Hydrazones as Biomembrane Penetration Enhancers: FT-IR Spectroscopy and Fluorescence Probe Studies. Molecules 2021; 27:molecules27010206. [PMID: 35011438 PMCID: PMC8746376 DOI: 10.3390/molecules27010206] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 12/27/2021] [Accepted: 12/29/2021] [Indexed: 11/16/2022] Open
Abstract
Hydrazones based on mono- and bicyclic terpenoids (verbenone, menthone and carvone) have been investigated in vitro as potential biomembrane penetration enhancers. In this regard, liposomes composed of lecithin or cardiolipin as phospholipid phase components with incorporated fluorescence probes have been prepared using the thin-film ultrasonic dispersion method. The mean particle size of the obtained liposomes, established using laser diffraction, was found to be 583 ± 0.95 nm, allowing us to categorize them as multilamellar vesicles (MLVs) according to their morphology. Pursuant to fluorescence analysis, we may assume a reduction in microviscosity and, consequently, a decrease in the packing density of lecithin and cardiolipin lipids to be the major mechanism of action for terpenoid hydrazones 1–15. In order to determine the molecular organization of the lipid matrix, lipids were isolated from rat strata cornea (SCs) and their interaction with tested compounds was studied by means of Fourier transform infrared spectroscopy. FT-IR examination suggested that these hydrazones fluidized the SC lipids via the disruption of the hydrogen-bonded network formed by polar groups of SC constituents. The relationship between the structure of terpenoid hydrazones and their ability to enhance biomembrane penetration is discussed.
Collapse
Affiliation(s)
- Mariia Nesterkina
- Department of Organic and Pharmaceutical Technologies, Odessa National Polytechnic University, 65044 Odessa, Ukraine;
- Correspondence: ; Tel.: +38-093-713-38-53
| | - Serhii Smola
- A.V. Bogatsky Physico-Chemical Institute, National Academy of Sciences of Ukraine, 65080 Odessa, Ukraine; (S.S.); (N.R.)
| | - Nataliya Rusakova
- A.V. Bogatsky Physico-Chemical Institute, National Academy of Sciences of Ukraine, 65080 Odessa, Ukraine; (S.S.); (N.R.)
| | - Iryna Kravchenko
- Department of Organic and Pharmaceutical Technologies, Odessa National Polytechnic University, 65044 Odessa, Ukraine;
| |
Collapse
|
2
|
Yu Y, Wang L, Han J, Wang A, Chu L, Xi X, Kan R, Sha C, Sun K. Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study. J Pharm Sci 2021; 110:3431-3438. [PMID: 34147518 DOI: 10.1016/j.xphs.2021.06.025] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 06/11/2021] [Accepted: 06/14/2021] [Indexed: 12/23/2022]
Abstract
Temozolomide is a first-line therapeutic drug for glioblastoma (GBM), and it has a low solubility, short biological half-life, and resistance to drug limits in clinical applications. Therefore, it is necessary to find more effective anti-tumor drugs to overcome drug resistance and enhance its anti-glioma activity. We therefore used n-butanol, n-hexanol, n-octanol, 1-dodecanol and 1-hexadecanol to synthesize a series of temozolomide ester compounds (TMZEs) and then investigated their physicochemical properties and anti-glioma efficacy. Our results showed that TMZEs had a higher lipophilicity compared to TMZ and could stably exist in plasma and brain homogenates. TMZEs had significantly increased cytotoxicity and cellular uptake in C6 glioma cells as chain lengths increased. Additionally, the IC50 of TMZ-16E towards TMZ-resistant cells (T98G) was 85.9-fold lower than that of TMZ (p < 0.001), and Western blot results demonstrated that TMZ-16E could significantly reduce the expression of O6-methylguanine-DNA-methyltransferase (MGMT). The in vivo anti-glioma efficacy of TMZ-16E were then investigated in orthotopic and subcutaneous GBM models. TMZ-16E prolonged the survival time to 35 days in orthotopic glioma bearing rats, which was 1.94-fold longer than the survival time of rats treated with TMZ, and TMZ-16E increased tumor cell apoptosis based on TUNEL staining. Moreover, TMZ-16E (50 mg/kg) noticeably slowed the growth of T98G subcutaneous tumors by down-modulating MGMT expression in subcutaneous GBM-bearing mice, indicating that TMZ-16E could effectively reverse drug resistance. In conclusion, TMZEs improved the lipophilicity and stability of these drugs. Especially, TMZ-16E could reverse drug resistance and improve therapeutic effects of TMZ, which has clinical application potential for GBM treatment.
Collapse
Affiliation(s)
- Yawen Yu
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China
| | - Liangxiao Wang
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China
| | - Junping Han
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China
| | - Aiping Wang
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.
| | - Liuxiang Chu
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China
| | - Xinran Xi
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China
| | - Ronglin Kan
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China
| | - Chunjie Sha
- State Key Laboratory of Long-Acting and Targeting Drug Delivery System, Luye Pharmaceutical Co., Ltd., Yantai 264003, PR China
| | - Kaoxiang Sun
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China
| |
Collapse
|
3
|
Shah K, Gupta JK, Chauhan NS, Upmanyu N, Shrivastava SK, Mishra P. Prodrugs of NSAIDs: A Review. THE OPEN MEDICINAL CHEMISTRY JOURNAL 2017; 11:146-195. [PMID: 29387273 PMCID: PMC5748882 DOI: 10.2174/1874104501711010146] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/13/2017] [Revised: 10/24/2017] [Accepted: 10/30/2017] [Indexed: 01/04/2023]
Abstract
INTORODUCTION Prodrug approach deals with chemical biotransformation or enzymatic conversion or involves inactive or less active bio-reversible derivatives of active drug molecules. They have to pass through enzymatic or chemical biotransformation before eliciting their pharmacological action. METHODS & MATERIALS The two different pharmacophores combine to give synergistic activity or may help in targeting the active drug to its target. Prodrug super seeds the problems of prodrug designing, for example solubility enhancement, bioavailability enhancement, chemical stability improvement, presystemic metabolism, site specific delivery, toxicity masking, improving patient acceptance, or eradicating undesirable adverse effects. RESULTS As an outcome the search for a prodrug or mutual prodrug with reduced toxicity has continued during recent years. This present review emphasizes the common help to revamp physiochemical, pharmaceutical and therapeutic effectiveness of drugs. CONCLUSION This gives the researcher a common platform where they can find prodrugs of commonly used NSAIDs to overcome the gastrointestinal toxicity (irritation, ulcergenocity and bleeding).
Collapse
Affiliation(s)
- Kamal Shah
- Institute of Pharmaceutical Research, GLA University, Mathura, U.P.- 281406, India
| | - Jeetendra K. Gupta
- Institute of Pharmaceutical Research, GLA University, Mathura, U.P.- 281406, India
| | | | - Neeraj Upmanyu
- School of Pharmacy & Research, Peoples University, Bhopal, M.P.- 462037, India
| | - Sushant K. Shrivastava
- Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi U.P.- 221005, India
| | - Pradeep Mishra
- Institute of Pharmaceutical Research, GLA University, Mathura, U.P.- 281406, India
| |
Collapse
|
4
|
Peesa JP, Yalavarthi PR, Rasheed A, Mandava VBR. A perspective review on role of novel NSAID prodrugs in the management of acute inflammation. JOURNAL OF ACUTE DISEASE 2016. [DOI: 10.1016/j.joad.2016.08.002] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
5
|
Pawar V, Thosani R, Kanhed A, Giridhar R, Yadav MR. Potential of Piperazinylalkylester Prodrugs of 6-Methoxy-2-Naphthylacetic Acid (6-MNA) for Percutaneous Drug Delivery. AAPS PharmSciTech 2015; 16:518-27. [PMID: 25370023 DOI: 10.1208/s12249-014-0240-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2014] [Accepted: 10/09/2014] [Indexed: 11/30/2022] Open
Abstract
Piperazinylalkyl ester prodrugs (4a-5d) of 6-methoxy-2-naphthylacetic acid (6-MNA) (1) were synthesized and evaluated in vitro for the purpose of percutaneous drug delivery. These ionizable prodrugs exhibited varying aqueous solubilities and lipophilicities depending on the pH of the medium. The prodrugs (4a-5c) showed higher aqueous solubility and similar lipophilicity at pH 5.0 and lower aqueous solubility and higher lipophilicity at pH 7.4 in comparison to 6-MNA. The chemical and enzymatic hydrolyses of the prodrugs was investigated in aqueous buffer solutions (pH 5.0 and 7.4) and in 80% human serum (pH 7.4) at 37°C. The prodrugs showed moderate chemical stability (t 1/2 = 6-60 h) but got readily hydrolyzed enzymatically to 6-MNA with half-life ranging from 10-60 min. In the in vitro permeation study using rat skin, the flux of 6-MNA and the prodrugs was determined in aqueous buffers of pH 5.0 and 7.4. The prodrug (5b) showed 7.9- and 11.2-fold enhancement in skin permeation compared to 6-MNA (1) at pH 5.0 and 7.4, respectively. It was concluded that the parent NSAIDs having favorable pharmacokinetic and pharmacodynamic properties coupled with increased skin permeability of their prodrugs could give better options for the treatment of rheumatic diseases.
Collapse
|
6
|
N'Da DD. Prodrug strategies for enhancing the percutaneous absorption of drugs. Molecules 2014; 19:20780-807. [PMID: 25514222 PMCID: PMC6271867 DOI: 10.3390/molecules191220780] [Citation(s) in RCA: 79] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2014] [Revised: 12/03/2014] [Accepted: 12/04/2014] [Indexed: 12/13/2022] Open
Abstract
The transdermal application of drugs has attracted increasing interest over the last decade or so, due to the advantages it offers, compared to other delivery methods. The development of an efficient means of transdermal delivery can increase drug concentrations, while reducing their systemic distribution, thereby avoiding certain limitations of oral administration. The efficient barrier function of the skin, however, limits the use of most drugs as transdermal agents. This limitation has led to the development of various strategies to enhance drug-skin permeation, including the use of penetration enhancers. This method unfortunately has certain proven disadvantages, such as the increased absorption of unwanted components, besides the drug, which may induce skin damage and irritancy. The prodrug approach to increase the skin’s permeability to drugs represents a very promising alternative to penetration enhancers. The concept involves the chemical modification of a drug into a bioreversible entity that changes both its pharmaceutical and pharmacokinetic characteristics to enhance its delivery through the skin. In this review; we report on the in vitro attempts and successes over the last decade by using the prodrug strategy for the percutaneous delivery of pharmacological molecules.
Collapse
Affiliation(s)
- David D N'Da
- Centre of Excellence for Pharmaceutical Sciences (PHARMACEN), North-West University, Potchefstroom 2520, South Africa.
| |
Collapse
|
7
|
Liu KS, Hsieh PW, Aljuffali IA, Lin YK, Chang SH, Wang JJ, Fang JY. Impact of ester promoieties on transdermal delivery of ketorolac. J Pharm Sci 2014; 103:974-86. [PMID: 24481782 DOI: 10.1002/jps.23888] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2013] [Revised: 12/15/2013] [Accepted: 01/10/2014] [Indexed: 12/22/2022]
Abstract
Different types of ketorolac ester prodrugs incorporating tert-butyl (KT), benzyl (KB), heptyl (KH), and diketorolac heptyl (DKH) promoieties were synthesized for the comparison of percutaneous penetration. The prodrugs were characterized according to their melting point, capacity factor, lipophilicity, solubility in 30% ethanol/buffer, enzymatic hydrolysis, in vitro skin permeation, hair follicle accumulation, and in vivo skin tolerance. Interactions between the prodrugs and esterases were predicted by molecular docking. Both equimolar suspensions and saturated solutions in 30% ethanol/pH 7.4 buffer were employed as the applied dose. All of the prodrugs exhibited a lower melting point than ketorolac. The lipophilicity increased in the following order: ketorolac < KT < KB < KH < DKH. The prodrugs were rapidly hydrolyzed to the parent drug in esterase medium, skin homogenate, and plasma, with KT and KB exhibiting higher degradation rates. KT exhibited the highest skin permeation, followed by KB. The flux of KT and KB exceeded that of ketorolac by 2.5-fold and twofold, respectively. KH and DKH did not improve ketorolac permeation but exhibited a sustained release behavior. KT and KH revealed selective absorption into follicles and a threefold greater follicular uptake compared with ketorolac. KB, KH, and DKH slightly but significantly increased transepidermal water loss (TEWL) after consecutive administration for 7 days, whereas ketorolac and KT exhibited no influence on TEWL. According to the experimental results, it can be concluded that an optimal balance between lipophilicity and aqueous solubility is important in the design of a successful prodrug. The acceptable skin tolerance for safe application is also an important consideration.
Collapse
Affiliation(s)
- Kuo-Sheng Liu
- Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan, Taiwan
| | | | | | | | | | | | | |
Collapse
|
8
|
Qandil AM. Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review. Int J Mol Sci 2012; 13:17244-74. [PMID: 23247285 PMCID: PMC3546748 DOI: 10.3390/ijms131217244] [Citation(s) in RCA: 86] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2012] [Revised: 11/29/2012] [Accepted: 12/10/2012] [Indexed: 12/15/2022] Open
Abstract
The design and the synthesis of prodrugs for nonsteroidal anti-inflammatory drugs (NSAIDs) have been given much attention by medicinal chemists, especially in the last decade. As a therapeutic group, NSAIDs are among the most widely used prescribed and over the counter (OTC) medications. The rich literature about potential NSAID prodrugs clearly shows a shift from alkyl, aryalkyl or aryl esters with the sole role of masking the carboxylic acid group, to more elaborate conjugates that contain carefully chosen groups to serve specific purposes, such as enhancement of water solubility and dissolution, nitric oxide release, hydrogen sulfide release, antioxidant activity, anticholinergic and acetylcholinesterase inhibitory (AChEI) activity and site-specific targeting and delivery. This review will focus on NSAID prodrugs that have been designed or were, later, found to possess intrinsic pharmacological activity as an intact chemical entity. Such intrinsic activity might augment the anti-inflammatory activity of the NSAID, reduce its side effects or transform the potential therapeutic use from classical anti-inflammatory action to something else. Reports discussed in this review will be those of NO-NSAIDs, anticholinergic and AChEI-NSAIDs, Phospho-NSAIDs and some miscellaneous agents. In most cases, this review will cover literature dealing with these NSAID prodrugs from the year 2006 and later. Older literature will be used when necessary, e.g., to explain the chemical and biological mechanisms of action.
Collapse
Affiliation(s)
- Amjad M Qandil
- Pharmaceutical Sciences Department, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia.
| |
Collapse
|
9
|
Qandil AM, Jamhawi NM, Tashtoush BM, Al-Ajlouni AM, Idkaidek NM, Obaidat AA. The hydrolysis kinetics of monobasic and dibasic aminoalkyl esters of ketorolac. Drug Dev Ind Pharm 2012; 39:1346-56. [PMID: 22995063 DOI: 10.3109/03639045.2012.712535] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Six aminoethyl and aminobutyl esters of ketorolac containing 1-methylpiperazine (MPE and MPB), N-acetylpiperazine (APE and APB) or morpholine (ME and MB), were synthesized and their hydrolysis kinetics were studied. The hydrolysis was studied at pH 1 to 9 (for MPE, APE and ME) and pH 1 to 8 (for MPB, APB and MB) in aqueous phosphate buffer (0.16 M) with ionic strength (0.5 M) at 37°C. Calculation of k(obs), construction of the pH-rate profiles and determination of the rate equations were performed using KaleidaGraph® 4.1. The hydrolysis displays pseudo-first order kinetics and the pH-rate profiles shows that the aminobutyl esters, MPE, APB and MB, are the most stable. The hydrolysis of the ethyl esters MPE, APE and ME, depending on the pH, is either fast and catalyzed by the hydroxide anion or slow and uncatalyzed for the diprotonated, monoprotonated and nonprotonated forms. The hydrolysis of the butyl esters showed a similar profile, albeit it was also catalyzed by hydronium cation. In addition, the hydroxide anion is 105 more effective in catalyzing the hydrolysis than the hydronium cation. The hydrolysis pattern of the aminoethyl esters is affected by the number and pKa of its basic nitrogen atoms. The monobasic APE and ME, show a similar hydrolysis pattern that is different than the dibasic MPE. The length of the side chain and the pKa of the basic nitrogen atoms in the aminoethyl moiety affect the mechanism of hydrolysis as the extent of protonation at a given pH is directly related to the pKa.
Collapse
Affiliation(s)
- Amjad M Qandil
- Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan.
| | | | | | | | | | | |
Collapse
|
10
|
Pan J, Ma L, Li B, Li Y, Guo L. Novel Dendritic Naproxen Prodrugs with Poly(aspartic Acid) Oligopeptide: Synthesis and Hydroxyapatite Binding in Vitro. SYNTHETIC COMMUN 2012. [DOI: 10.1080/00397911.2011.584259] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Junzhu Pan
- a Key Laboratory of Drug Targeting and Drug Delivery System of Education Ministry, Department of Medicinal Chemistry , West China School of Pharmacy, Sichuan University , Chengdu , China
| | - Lifang Ma
- b School of Chemical Engineering, Sichuan University , Chengdu , China
| | - Bo Li
- a Key Laboratory of Drug Targeting and Drug Delivery System of Education Ministry, Department of Medicinal Chemistry , West China School of Pharmacy, Sichuan University , Chengdu , China
| | - Yanhua Li
- a Key Laboratory of Drug Targeting and Drug Delivery System of Education Ministry, Department of Medicinal Chemistry , West China School of Pharmacy, Sichuan University , Chengdu , China
| | - Li Guo
- a Key Laboratory of Drug Targeting and Drug Delivery System of Education Ministry, Department of Medicinal Chemistry , West China School of Pharmacy, Sichuan University , Chengdu , China
| |
Collapse
|
11
|
Dąbrowska M, Starek M, Skuciński J. Lipophilicity study of some non-steroidal anti-inflammatory agents and cephalosporin antibiotics: A review. Talanta 2011; 86:35-51. [DOI: 10.1016/j.talanta.2011.09.017] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2011] [Revised: 09/05/2011] [Accepted: 09/12/2011] [Indexed: 02/03/2023]
|
12
|
Qandil AM, El Mohtadi FH, Tashtoush BM. Chemical and in vitro enzymatic stability of newly synthesized celecoxib lipophilic and hydrophilic amides. Int J Pharm 2011; 416:85-96. [DOI: 10.1016/j.ijpharm.2011.06.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2011] [Revised: 06/06/2011] [Accepted: 06/09/2011] [Indexed: 12/20/2022]
|
13
|
Israel B, Garner ST, Thakare M, Elder D, Abney T, Azadi P, Beach JW, Price JC, Ahmed H, Capomacchia AC. Transdermal permeation of novel n-acetyl-glucosamine/NSAIDs mutual prodrugs. Pharm Dev Technol 2010; 17:48-54. [PMID: 20858066 DOI: 10.3109/10837450.2010.513987] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The current investigation reports skin permeation of three novel mutual prodrugs (MP) which couple n-acetyl-glucosamine with an NSAID, either ketoprofen or ibuprofen. They were evaluated for transdermal permeation using shed snakeskin, and to our knowledge represent the first MPs synthesized for this purpose, although they also could be used for subcutaneous delivery. MPs are defined as two active drug compounds usually connected by an ester linkage. Glucosamine administration has been linked to damaged cartilage repair, and pain relief in joints afflicted with osteoarthritis. NSAIDs are commonly used orally in transdermal creams or gels for joint pain relief. Two novel compounds we report (MP1 and MP2) covalently link ibuprofen and ketoprofen directly to the amide nitrogen of n-acetyl-glucosamine (NAG); the other compound (MP3) covalently links ibuprofen to the amide nitrogen, using a short chain acetyl linker. Permeability studies show that the ketoprofen mutual prodrug (MP2) permeates shed snakeskin more than three times greater than either ibuprofen derivative, while ethanol markedly increases the permeation for all three. The ketoprofen mutual prodrug appears the most likely candidate for transdermal administration; all three mutual prodrugs may be candidates for subcutaneous injection.
Collapse
Affiliation(s)
- Bridg'ette Israel
- Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, The University of Georgia, Athens, Georgia
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 2010; 1:109-31. [PMID: 21132122 PMCID: PMC2995530 DOI: 10.4155/tde.10.16] [Citation(s) in RCA: 325] [Impact Index Per Article: 23.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Transdermal drug delivery is an exciting and challenging area. There are numerous transdermal delivery systems currently available on the market. However, the transdermal market still remains limited to a narrow range of drugs. Further advances in transdermal delivery depend on the ability to overcome the challenges faced regarding the permeation and skin irritation of the drug molecules. Emergence of novel techniques for skin permeation enhancement and development of methods to lessen skin irritation would widen the transdermal market for hydrophilic compounds, macromolecules and conventional drugs for new therapeutic indications. As evident from the ongoing clinical trials of a wide variety of drugs for various clinical conditions, there is a great future for transdermal delivery of drugs.
Collapse
Affiliation(s)
- Kalpana S Paudel
- College of Pharmacy, University of Kentucky, Lexington, KY 40536-0200, USA
| | - Mikolaj Milewski
- College of Pharmacy, University of Kentucky, Lexington, KY 40536-0200, USA
| | - Courtney L Swadley
- College of Pharmacy, University of Kentucky, Lexington, KY 40536-0200, USA
| | - Nicole K Brogden
- College of Pharmacy, University of Kentucky, Lexington, KY 40536-0200, USA
| | - Priyanka Ghosh
- College of Pharmacy, University of Kentucky, Lexington, KY 40536-0200, USA
| | - Audra L Stinchcomb
- College of Pharmacy, University of Kentucky, Lexington, KY 40536-0200, USA
| |
Collapse
|
15
|
Curcio A, Sasso O, Melisi D, Nieddu M, La Rana G, Russo R, Gavini E, Boatto G, Abignente E, Calignano A, Rimoli MG. Galactosyl Prodrug of Ketorolac: Synthesis, Stability, and Pharmacological and Pharmacokinetic Evaluations. J Med Chem 2009; 52:3794-800. [DOI: 10.1021/jm900051r] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Annalisa Curcio
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Oscar Sasso
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Daniela Melisi
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Maria Nieddu
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Giovanna La Rana
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Roberto Russo
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Elisabetta Gavini
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Gianpiero Boatto
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Enrico Abignente
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Antonio Calignano
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| | - Maria Grazia Rimoli
- Department of Pharmaceutical and Toxicological Chemistry and Department of Experimental Pharmacology, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131, Naples, Italy, and Department of Drug, Chemistry and Toxicology and Department of Drug Sciences, Faculty of Pharmacy, University of Sassari, Via Muroni 23/a, 07100, Sassari, Italy
| |
Collapse
|